1. Home
  2. CKX vs BCDA Comparison

CKX vs BCDA Comparison

Compare CKX & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$11.06

Market Cap

22.3M

Sector

Energy

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.20

Market Cap

17.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
BCDA
Founded
1930
N/A
Country
United States
United States
Employees
N/A
21
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
17.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CKX
BCDA
Price
$11.06
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
10.2K
6.2M
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
1125.00
N/A
EPS
0.03
N/A
Revenue
$838,543.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$368.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$0.78
52 Week High
$13.00
$2.45

Technical Indicators

Market Signals
Indicator
CKX
BCDA
Relative Strength Index (RSI) 50.82 64.58
Support Level $11.03 $1.11
Resistance Level $11.76 $1.34
Average True Range (ATR) 0.60 0.11
MACD -0.04 0.04
Stochastic Oscillator 33.60 87.10

Price Performance

Historical Comparison
CKX
BCDA

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: